See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $53.2B | 3.1x | 10.6x | |
| $3.1B | 5.8x | 16.9x | |
| $3.0B | n/a | n/a | |
| $2.8B | 10.3x | -33.7x | |
| $2.3B | 2.7x | 13.8x | |
| $2.3B | 30.4x | -17.0x | |
| $2.1B | 0.9x | 6.1x | |
| $2.1B | 9.1x | 36.0x | |
| $1.8B | 6.1x | 12.7x | |
| $1.6B | 66.4x | n/a | |
| $1.5B | 6.3x | 18.2x | |
| $1.4B | 7.1x | n/a | |
| $1.4B | 8.6x | 84.7x | |
| $1.0B | 8.5x | 19.8x | |
| $1.0B | 7.4x | -24.9x | |
| $819M | n/a | n/a | |
| $782M | 20.1x | -12.5x | |
| $725M | 3.2x | 23.9x | |
| $714M | 6.2x | 35.0x | |
| $705M | 5.6x | n/a | |
| $679M | n/a | -25.6x | |
| $594M | 27.2x | n/a | |
| $593M | 6.7x | 19.5x | |
| $547M | 1.9x | 4.4x | |
| $508M | n/a | -6.2x | |
| $266M | 144.4x | -61.1x | |
| $231M | 2.1x | 94.6x | |
| $227M | 26.5x | n/a | |
| $201M | n/a | -7.2x | |
| $148M | 6.4x | -5.7x | |
| $109M | 0.4x | 3.4x | |
| $107M | n/a | n/a | |
| $104M | 5.9x | n/a | |
| $58.5M | 5.5x | n/a | |
| $52.7M | 1.7x | n/a | |
| $48.6M | n/a | -0.5x | |
| $10.7M | 0.2x | 0.6x | |
| -$1.2M | -3.3x | n/a | |
| -$89.2M | n/a | 0.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules